The statement on Michele Gazzoli
Astana Qazaqstan Team received an official notification from the UCI regarding a 1-year period of ineligibility imposed on the rider Michele Gazzoli as the consequences of the presence of a Prohibited Substance Tuaminoheptane in the rider’s A Sample collected during an in-competition doping control on February 17th at the Volta ao Algarve em Bicicleta.
As part of this case, Astana Qazaqstan Team received from Michele Gazzoli a full explanation on how the above-named substance entered his body. These explanations have also been presented and thoroughly reviewed by the UCI.
The UCI considered the explanations provided by Michele Gazzoli, namely the fact that the above-named substance entered the body unintentionally from the ingestion of a medication named Rhinofluimucil (a nasal spray for the treatment of rhinitis), purchased at a pharmacy independently without any implication of the medical staff of Astana Qazaqstan Team. The UCI decided this case was classified as an unintentional violation of anti-doping rule, which is why the disciplinary penalty was limited to one year of ineligibility and disqualification of the results of one race Volta ao Algarve em Bicicleta only.
Astana Qazaqstan Team categorically emphasizes that the team has nothing to do with this unfortunate violation of anti-doping rule by the rider Michele Gazzoli.
Astana Qazaqstan Team, adhering to the zero tolerance policy, decided to immediately terminate the contract with Michele Gazzoli.